GACM
TTPH

Green Arrow Capital Management’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

Green Arrow Capital Management’s Portfolio TTPH Stock Details TTPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-3,000
Closed -$1.2M – 184
2014
Q3 		$1.2M Hold
3,000
– – 0.1% 140
2014
Q2 		$809K Sell
3,000
-3,250
-52% -$697K 0.1% 145
2014
Q1 		$1.36M Buy
+6,250
New +$1.74M 0.12% 175

Other funds holding TTPH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
IG
ING Group Amsterdam, Netherlands $16.4B AUM 34.6% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

Green Arrow Capital Management's TTPH Position: Q4 2014 in Review

Green Arrow Capital Management sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q4 2014, closing a stake of 3,000 shares — an estimated $1.2M sold.

Green Arrow Capital Management first reported a position in TTPH in Q1 2014 and held it in 3 quarters. The position peaked at $1.36M in Q1 2014. 96 funds tracked by Wall St. Rank hold TTPH as of Q4 2014.

  • Green Arrow Capital Management reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q4 2014 after selling out during the quarter.
  • Green Arrow Capital Management sold 3,000 Tetraphase Pharmaceuticals, Inc. shares in Q4 2014, an estimated $1.2M.
  • Green Arrow Capital Management first reported a position in Tetraphase Pharmaceuticals, Inc. in Q1 2014 and held it in 3 quarters.
  • Green Arrow Capital Management's Tetraphase Pharmaceuticals, Inc. position peaked at $1.36M in Q1 2014.
  • 96 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q4 2014.

Based on Green Arrow Capital Management's 13F filing for Q4 2014, filed 17 Feb 2015.